Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Information meeting on Europe's new partnership for health, Innovative Health Initiative (IHI)

Fysiskt på Vinnova, Mäster Samuelsgatan 56, eller digitalt via Teams Tue 24 May 2022 at 11:00-13:00

Welcome to the information meeting about Europe's new partnership for health, Innovative Health Initiative, IHI, and their first announcements that open in June 2022. Vinnova represents IHI in Sweden and invites you to a first information meeting.

This web page has been machine translated. If there are any uncertainties, please refer to the Swedish text.

Click here to join the meeting.

Innovative Health Initiative (IHI) is a newly established public-private partnership between EU Kommissionen and European industry organizations in the healthcare industry. COCIR, EFPIA (including Vaccines Europe), EuropaBio, and MedTech Europe.

In the coming years, IHI will fund cross-sectoral research and innovation projects that will contribute to health solutions for the benefit of patients and health care. In total, IHI is expected to allocate EUR 2.2 billion.

During the information meeting, you will hear about IHI's ambitions and plans, as well as about the first announcements that are expected to open in June 2022.

You can also take part in experiences from Swedish participants in project within Innovative Medicine Initiative (IMI), the programme that forms the basis for IHI.

The event is aimed at those who are interested in applying for and participating in upcoming calls, or who can support potential applicant (eg industry, academia, small and medium-sized companies, patient associations, intermediaries at grant offices, industry organizations)


  • Introduction, Lars Hammarström, head of division Health Division, Vinnova
  • Introduction about IHI and upcoming announcements, Pierre Meulien, Executive Director IHI
  • Questions and discussion
  • Break with coffee and fruit
  • Two previous IMI project with Swedish participation share their experiences:

    - IMI 1 project ENABLE, Anders Karlén, Uppsala Universitet ENABLE | IMI Innovative Medicines Initiative (

    - IMI 2 project MAD-CoV 2, Ali Mirazimi, SVA
    MAD-CoV 2 | IMI Innovative Medicines Initiative (

  • Questions and discussion with all presenters
  • Closing, Vinnova

The meeting will be held in English.

You can ask questions before and during the meeting at To ask questions, use the link or the Menti code 4942 2170.

The meeting will not be recorded.


You who want to participate on site at Vinnova register at no later than 17 May.

For those who participate digitally, no registration is required. A link to Teams will be published on this page well in advance of the meeting.

Sometimes we photograph or video record our activities. If you don't want to participate in photos or videos, please let us when you arrive.

You have chosen to disallow certain cookies and funtions on our website, such as map services from Google Maps. You can change your privacy settings at any time to allow these functions and get a better experience.

Change privacy settings

N: 59.33263290000001 E: 18.0611227 (Show on map)


Gunnar Sandberg

Programme Manager

Caroline Ekstrand

Programme Manager

+46 8 473 30 27

Last updated 10 May 2022

Page statistics